Skip to main content

Final California Marijuana Industry Rules May Not Be Made Public Until January

Although California’s final cannabis industry regulations will reportedly be completed Monday, many industry insiders likely won’t be able to read them until January.

That may be a disappointment to marijuana businesses that were anticipating being able to see the final rules sooner than later.

“We expect to send our final version of permanent regulations to the Office of Administrative Law (OAL) on Monday, Dec. 3,” Alex Traverso, spokesman for the California Bureau of Cannabis Control (BCC), wrote in an email to Marijuana Business Daily.

“That will kick off a 30-day review period for OAL. The regulations will not be made public while OAL conducts its review,” he added.

Traverso wrote that the anticipated public release of final regulations after the OAL has given approval is “likely in early- (or) mid-January.”

He noted the BCC is exploring possible ways to make the regulations public sooner.

The state’s Department of Food and Agriculture, which oversees cultivators, and the Department of Public Health, which governs MJ manufacturers, will also be sending final rules to the OAL on Monday.

A similar timeline is expected for the regulations to be made public from all three agencies.

The regulations have taken more than a year for state officials to craft, and they have gone through multiple revisions throughout 2018.

The latest drafts of permanent rules were released Oct. 19.

Traverso said that until the OAL approves the final rules, the industry will be governed by emergency regulations that were re-adopted in June.

The OAL did not immediately respond to a MJBizDaily‘s request for comment as to when the final regulations might be published online.

John Schroyer can be reached at [email protected]

Original Article Source: https://mjbizdaily.com/final-california-marijuana-industry-rules-may-not-be-made-public-until-january/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...